Skip to content
10-Q

Quarterly Report

SANGUI BIOTECH INTERNATIONAL INC

0001551163-19-000243

← back to feed
Filed
Nov 13, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · Nov 13, 2019 201.48M sh
Short Term Debt Q1 2020 · Sep 30, 2019 $479.94K
Short Term Debt Q1 2020 · Jun 30, 2019 $478.36K
Stockholders Equity Q1 2020 · Sep 30, 2019 $54.24K
Stockholders Equity Q1 2020 · Jun 30, 2019 $49.2K
Current Liabilities Q1 2020 · Sep 30, 2019 $633.96K
Current Liabilities Q1 2020 · Jun 30, 2019 $670.96K
Current Assets Q1 2020 · Sep 30, 2019 $41.09K
Current Assets Q1 2020 · Jun 30, 2019 $78.97K
Total Assets Q1 2020 · Sep 30, 2019 $45.75K
Total Assets Q1 2020 · Jun 30, 2019 $78.97K
Cost Of Revenue Q1 2020 · Sep 30, 2019 $0
Cost Of Revenue Q1 2020 · Sep 30, 2018 $73
Operating Cash Flow Q1 2020 · Sep 30, 2018 −$133.74K
Cash And Equivalents Q1 2020 · Sep 30, 2018 $49.8K
Cash And Equivalents Q1 2020 · Jun 30, 2018 $20.94K
Sga Expense Q1 2020 · Sep 30, 2018 $46.79K
Rd Expense Q1 2020 · Sep 30, 2018 $7.97K
Net Income restated Q1 2020 · Sep 30, 2018 −$89.96K
Operating Income Q1 2020 · Sep 30, 2018 −$93.5K
Gross Profit Q1 2020 · Sep 30, 2018 $11.2K
Revenue Q1 2020 · Sep 30, 2018 $11.27K